The global medical industry experienced a 26% rise in company filings mentions of cloud in Q1 2023 compared with the previous quarter, with the highest share accounted for by ResMed with 41% year-on-year increase, according to GlobalData’s analysis of over 130 medical company filings.

Notably, cloud was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead of environment and social, according to GlobalData.

Of the 50 leading companies in the medical industry, ResMed had the greatest increase in references for cloud in Q1 2023, compared with the previous quarter. GlobalData identified 41 cloud-related sentences in the company's filings, an increase of 100% in Q1 2023 compared with Q4 2022. Idexx Laboratories's mentions of cloud rose by 200% to 16 and GE HealthCare Technologies's by 100% to 13 and Insulet's by 100% to 6 and DexCom's by 200% to 3.

GlobalData's Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cloud in Q1 2023 was 98.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.